SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Nereus -- Ignore unavailable to you. Want to Upgrade?


To: Mike McFarland who wrote (7)8/29/2006 9:16:43 PM
From: Mike McFarlandRespond to of 19
 
NPI-2358 demonstrated it is a potent and selective tumor vascular disrupting agent (VDA).
nereuspharm.com

Nereus will be at the 4th Annual "Angiogenesis and Vascular
Targeting Agents in Drug Discovery & Development" in Boston,
MA September 19 to 20, 2006



To: Mike McFarland who wrote (7)8/29/2006 10:50:05 PM
From: Steve LoknessRead Replies (1) | Respond to of 19
 
ocean muck is a good place to look.

Anyone else looking in "ocean muck" for potentials? Seems to me I remember DVSA doing so - if their targets are more general. Anyone else?

From a pragmatic point of view, is there any hint that nereus is thinking now about an IPO?

Steve